ity of these posttransplant lymphoproliferative disPersons undergoing maintenance immunosuppres-eases are B-cell non-Hodgkin lymphomas and are ususive treatment (MIST) were shown to be at increased ally EBV related. Malignancies of B cells in a more risk for the development of early malignancies, often mature stage are rare (5). Very little is known about of cells of the immune system. Very little is known the late effects of MIST. In some older studies the late about the late effects of MIST. Some clinical studies effects of selected immunosuppressants on immunoindicated an age-related increase in the incidence of competence were studied (6-8); however, any informaplasma-cell disorders, in particular in that of multiple tion on the late effects of more recently introduced immyeloma (MM). In the present study the influence of munosuppressants is scarce (9). Our previous studies MIST on the development of monoclonal B-cell prolif-performed in man (10) We hypothesize that this will eventually lead in suscep- shown to increase 10-fold the incidence of spontaneous multiple myeloma. Unexpectedly, the same high inciThe aim of this study was to test this hypothesis in dence of MM and in addition the development of a life-a suitable animal model, because a follow-up investigashortening lymphoblastic lymphoma were found in a tion involving the whole life-span of an individual is high frequency in the control group that received necessary. The aging mice of the C57BL/KaLwRij Cremophor EL only, i.e., the solvent of Cyclosporin A. strain offer an appropriate experimental model for such Repeated experiments with another lot of Cremophor a study because these mice spontaneously develop high showed a 6-fold increased frequency of MM but no frequency monoclonal B-cell proliferative disorders lymphoblastic lymphoma. With respect to the life-span that are similar to those in humans (11-13). Two and the incidence of hemopoietic neoplasms the least widely used treatment protocols, azathioprine/predniharmful drugs for MIST appeared to be azathioprine/ solone and Cyclosporin A (CsA)/prednisolone, were prednisolone. The results of the experiments in this tested in young as well as in late adult mice. Both C57BL/KaLwRij mouse model give a warning for in-regiments were shown to increase the frequency of creased incidence of MM in susceptible aging individu-spontaneous multiple myeloma (MM) in mice of this als and address a question whether Cremophor EL is strain. Control experiments using Cremophor EL, the a safe solvent for Cyclosporin A. ᭧
INTRODUCTION

MATERIALS AND METHODS
The number of persons undergoing maintenance immunosuppressive treatment (MIST) for long periods of Mice time (i.e., recipients of organ transplantations, some patients with autoimmune disorders) grows steadily.
SPF derived female C57BL/KaLwRij mice from the colony of the TNO Institute for Experimental GerontolShort term evaluation studies suggest that they are at markedly increased risk for the development of malig-ogy in Rijswijk (presently TNO-Prevention and Health, Leiden, The Netherlands) were maintained under nancies, very often of lymphoid cells (1) (2) (3) (4) . The major-clean conventional conditions. Detailed information on Cremophor EL (Sigma Chemical Company, St. Louis, MO; lot 97F0246), 160 mg in 0.25 ml of 10% ethanol husbandry, health status, survival data, and age-related pathology of the strain has been published pre-and saline (Group C, young mice, n Å 51; adult mice, n Å 48). viously (14) . A complete necropsy was done on mice within 2 hr of death or immediately following euthanaDue to unexpected results in group C, several additional experiments were performed to test the Cremosia of moribund animals. Histological examination of representative samples of all relevant tissues was per-phor EL influence. They, however, could only be performed with another, more recent Cremophor EL (lot formed according to a standard protocol. Ultrastructural examination by electron microscopy was per-70H0361): Once a month, mice of group CR1 (n Å 15) received, intraperitoneally, a dose of Cremophor EL (in formed on bone marrow samples in mice suspected of having multiple myeloma.
0.25 ml) four times higher (650 mg) than those of group Young (4 to 5 months old) and adult (14 months old) C in the first experiment. The same dose was given to mice of the C57BL/KaLwRij strain were first immu-mice of the group CR2 (n Å 15), but only once a week. nized with a purified human IgG1-Lambda paraprotein Groups CR3 (n Å 15) and CR4 (n Å 15) represented (KAT). Each mouse received intraperitoneally 50 mg of the same conditions as group C in the first experiment; the protein dissolved in 0.1 ml phosphate-buffered sa-however, only mice of group CR4 were immunized with line (PBS) and emulsified with 0.1 ml of complete the human IgG1-Lambda paraprotein before starting Freund's adjuvant and boosted after 4 weeks with the MIST. Control mice were injected intraperitoneally same amount of protein dissolved in Incomplete with 0.25 ml PBS/10% ethanol solution, either once a Freund's adjuvant/PBS (1:1). The immunization was month (group K1) or once a week (group K2). All mice used to obtain an additional marker for the detection in the second experiment were approximately 6 months of some H-Ig that were expected to develop with aging. of age at the start of the experiment. Immunization by itself, using protein antigens and Freund's adjuvant or adjuvant alone, does not lead to Detection of Homogeneous Immunoglobulin the increased incidence of multiple myeloma as shown Components in our previous experiments (11, 15) .
One month later, the mice were submitted to MIST Blood samples were taken each 2 months and the by intraperitoneal route because administration per os sera were tested for the presence of homogeneous imdid not guarantee an equal intake of the drugs. The munoglobulin components (H-Ig) by high resolution mice received azathioprine (The Wellcome Foundation electrophoresis and immunoelectrophoresis (17) . The Ltd., London, UK) and prednisolone (prednisolone soappearance of H-Ig in the sera of individual mice was dium succinate, N.V. Organon, Oss, The Netherlands):
tentatively classified according to the following criteria Group A (young mice, n Å 50; adult mice, n Å 50); or (12): (1) H-Ig which progressively develop within 2 Cyclosporin A in solution for intravenous application months and reach levels above 5 mg/ml. This pattern (kindly donated by Sandoz AG, Basel, Switzerland) and is typical for multiple myeloma spontaneously apprednisolone: Group B (young mice, n Å 50; adult mice, pearing in this mouse strain at the frequency of about n Å 47). These drugs were given twice a week in doses 0.5%. (2) Distinct H-Ig with a concentration below 4 corresponding to those used in human MIST as calcumg/ml, which persist for at least 6 months and can be lated according to Freireich et al. (16) . The dosage detected till the death of the animals. This pattern is schedule was Azathioprine, first five doses 0.9 mg each typical for benign monoclonal gammopathy (BMG), a per mouse and further 0.4 mg/mouse; CsA, first six benign neoplasia of B cells, which is very frequent in doses 3.4 mg each per mouse and further 0.72 mg/ the C57BL/Ka mice. (3) Transient H-Ig components, mouse; prednisolone, first dose of 0.6 mg/mouse, six usually of a low concentration, appearing for a limited following doses of 0.3 mg/mouse and further 0.12 mg/ period of time. These H-Ig were described as resulting mouse, continued over the whole remaining life-spans from insufficient control of T-cell function in various of the mice. The average total doses received per mouse immunodeficiencies with preserved B-cell function (inwere MIST from late adult age, 27.3 mg of azathioprine cluding the immunodeficiency due to aging of the imand 9.0 mg of prednisolone, 47.5 mg of CsA, and 6.8 mune system). (4) H-Ig components which appeared mg of prednisolone; MIST started at young age, 53. 6 shortly before the death of the mice were considered mg of azathioprine and 17.6 mg of prednisolone, 117. 4 unclassifiable. mg of CsA, and 17.9 mg of prednisolone.
The potential specificity of H-Ig to the human IgG1-Control groups consisted of mice receiving the solLambda protein used for the immunization of the mice vent of the corresponding drug twice a week only, i.e., was tested by antigen-specific immunoblotting as de-0.25 ml PBS for azathioprine (Group D, young mice, n Å 28; adult mice, n Å 30) and the solvent for CsA, scribed previously (18). Statistical Analysis ethanol control groups. No differences were detected in life-spans of the PBS-control group D of the first Survival curves were estimated by the method of experiment and the PBS/ethanol control groups K1 and Kaplan-Meier with differences assessed by the logrank K2 in the second experiment (data not shown). test. Proportions were compared by chi-square analysis, using Yates continuity correction, or Fisher's exact test when a number was smaller than 5. P values smaller than 0.05 were considered statistically significant.
RESULTS
Survival
The life-span of mice in which MIST was started at the age of 6 months was not significantly different from the life-span of mice in which the same treatment-protocol was started at late adult age (data not shown). The treatment-protocol of group A, azathioprine and prednisolone, neither affected the life-span of young nor of adult mice as compared to the PBS-control group D (Table 1) . The young immunosuppressed mice in group B had a shorter life-span compared to the PBS-treated control group. While assessing differences between the CsA/prednisolone-treated group B and the Cremophor EL-treated group C, it became apparent that young mice in the control group C had a significantly shortened life-span as compared to young mice treated with the immunosuppressants. This was not the case in adult mice, but both young and adult mice treated with Cremophor EL had a significantly shortened life-span as compared to group D (P õ .001) (Fig. 1) .
Because of these adverse effects of Cremophor EL in group C, additional experiments were performed, although with a different batch of Cremophor EL. Only 
Homogeneous Immunoglobulin Components
tics of MM were detected in one case in group CR1 and one in group CR4. Thus the incidence of MM in the The frequency curve of H-Ig (Fig. 2) and its slope of later experiments in all Cremophore groups together the control mice receiving only PBS did not differ much was 3%. from those in untreated normal C57BL/KaLwRij mice as seen in numerous previous experiments (12). The H-Ig Isotypes and Specificity H-Ig frequency curve of mice receiving azathioprine/ prednisolone followed more or less that of its control Testing the isotypes of H-Ig revealed that 11 of the 17 MM were of the IgG2b isotype. Of the remaining 6 group, being only slightly higher in the beginning of the treatment. The frequencies of H-Ig in group C and MM, 4, 1, and 1 belonged, respectively, to the IgG2a, IgG1, and IgG3 subclasses. All of them were of the even more in the CsA/prednisolone-treated group B were clearly higher than that of group D for several kappa light chain type. The most frequent isotype of the H-Ig in the BMG group was IgG2a. H-Ig of the months after initiation of the treatment. At the end of the observation period, which is in fact determined by transient type were of various isotypes, including IgM.
There was no clear-cut H-Ig of the IgA isotype found the natural ending of the lives of the animals, the frequencies of H-Ig were similar in all groups, reaching in any of the groups.
Tests for the antibody specificity of individual H-Ig values above 70%. The characterization of the H-Ig components (Table 2) showed that the pattern of MM components to the antigen used for immunization revealed that one of 114 cases of BMG and one of 15 cases as detected in high resolution serum electrophoresis was seen in 5% of the mice in each of the groups A, B, of MM had a positive anti-human IgG activity. The latter was a mouse (BL-59) from group A, treated with and C, which was a 10 times higher incidence than was expected (P õ 0.0001, one-proportion frequency azathioprine/prednisolone. At the age of 22 months, this mouse developed an IgG2b-Kappa paraprotein analysis). Also transient small H-Ig components were most frequently seen in these three groups. No differ-that reached within the remaining 5 months of life a concentration far above 10 mg/ml (Fig. 3) . The epitope ence in the incidence of BMG was found. In group A the incidence of unclassified H-Ig was significantly on human IgG recognized by this mouse myeloma protein (as tested by a number of human IgG paraproteins lower than in the control group D. Over all, no differences were detected in H-Ig incidence and characteris-of different subclasses and light chain types) was shown to belong to a common determinant on the tics between groups B and C.
In the additional experiments on the effect of Cremo-gamma chain. Similar specificity was also found when the BMG H-Ig was tested. In none of the cases a speciphor EL, heavy H-Ig components with the characteris- ficity to IgG1 subclass, to lambda light chain type, or from young age with CsA/prednisolone (group B), the to the KAT-protein idiotype was detected. incidence of FCCL was significantly higher as compared to group C, but was not different when compared Histopathological Examination to the PBS control group D. Lymphoblastic lymphoma (LL) occurred significantly more in the group that had Hemopoietic neoplasms were common in all experireceived Cremophore EL, but was rare in the other mental groups (Table 3) , whereas other neoplasms treatment groups. This unexpected high incidence of were rare and randomly distributed over the experi-LL in group C was another reason to start the addimental groups. The most common neoplasm was the tional experiment. However, there was no LL found in follicular center cell lymphoma (FCCL), a slowly promice of this latter experiment. gressive malignancy of B cells (14). In mice treated Histiocytic sarcomas (HS) were moderately frequent in all groups. Twelve mice had more than one hemopoietic tumor: for mice had FCCL and HS, six mice had FCCL and LL, one mouse had LL and HS, and one mouse had FCCL, LL, and HS.
FCCL was most frequently found in the mesenteric lymph node, but other lymph nodes, spleen, and Peyer's patches were also commonly affected. The FCCL was characterized by nodular expansive growth and contained a mixed population of cells. The cells were small and large lymphoid cells mixed with variable numbers of plasma cells, macrophages, multinucleated cells, and granulocytes.
LL was characterized by infiltrative growth and was usually leukemic. Bone marrow involvement was com -FIG. 3 . Demonstration of the antibody activity to human IgG of mon. The neoplasm was present throughout the peritothe myeloma protein (BL59) by antigen-specific immunoblotting. The neal cavity and neoplastic cells infiltrated the abdomimembrane on the left side was coated with the purified human IgG1-nal viscera from the serosal surface or hematogenously. HS was primarily present in the liver, lung, lymph an age-related immunodeficiency and eventually leads in susceptible individuals to benign and malignant neonodes, and uterus. The tumor consisted of ovoid or spinplasias mainly of the B cells. This hypothesis seems to dle-shaped histiocytic cells. Multinucleated cells and be corroborated by the present experiments for at least erythrophagocytosis were common. the increased incidence of MM. A 10-fold increase in MM was characterized on light microscopy by the the incidence of MM was observed in both treatment presence of multiple foci of pleomorphic plasmacytoid regimens. The incidence of BMG, a benign B-cell neocells without distortion of the normal architecture of plasia, was not increased. However, BMG is a typical the bone marrow or osteolysis. These were most comphenomenon of old age and therefore, the shortened monly found in the pelvic bones and in the distal femur survival of the mice in some of the experimental groups and proximal tibia. Ultrastructural examination demmay have influenced the results. onstrated typical plasmacytoid cells with abundant
The frequency distribution of isotypes within H-Ig of rough endoplasmic reticulum and a well-developed the different categories was similar with that seen in Golgi apparatus.
other experiments (11, 12) . While the most frequent
DISCUSSION
isotype of H-Ig in BMG was IgG2a, in MM, typically, the IgG2b isotype was clearly dominant. An interesting Short term studies evaluating the effects of MIST on finding was the anti-IgG specificity of one MM and one the development of neoplasias showed an increased BMG to the protein used for immunization prior to risk of the treated persons for malignancies, very often the MIST initiation. Both paraproteins recognized a of lymphoid cells (1) (2) (3) (4) (5) . Only little is known about the common determinant on the human IgG1L protein. late effects of long-lasting MIST. Literature review (5) This indicated that both BMG and MM developed from and preliminary data from our studies on kidney recipi-B-cell clones responding to a specific antigenic stimulaents (10) indicated increased frequencies of MM and tion, even very long before the disorder developed. As BMG that were related more to the higher age than to also our other previous experiments indicated (11, 15) , the duration of MIST. This led to the hypothesis that it may be the memory B cell that becomes target for oncogenic events. MIST accelerates and potentiates the development of As far as the other malignancies are concerned, there any long-term immunosuppression protocols could be avoided or adapted to minimize the risks. was no significant difference in the occurrence of HS among the four groups. Young mice in group C had the ACKNOWLEDGMENT lowest incidence of FCCL, even less than control group D. Since FCCL is a disease of old age, the shortened The excellent assistance of Mrs. E. Blauw in the electron microssurvival of these mice can explain this finding. Alcopy studies was greatly appreciated. though malignant LL was detected in a few mice of the MIST-treated groups and once in the PBS-control
